![Janet E. Buhlmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Dr. Janet E.
Buhlmann is a Director-Molecular Immunology at EpiVax, Inc.
She received her undergraduate degree from Mount Holyoke College and a doctorate degree from Dartmouth College.
Precedenti posizioni note di Janet E. Buhlmann
Società | Posizione | Fine |
---|---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Corporate Officer/Principal | - |
Formazione di Janet E. Buhlmann
Mount Holyoke College | Undergraduate Degree |
Dartmouth College | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |
- Borsa valori
- Insiders
- Janet E. Buhlmann